Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI109442

Evidence that Increased Circulating 1α,25-Dihydroxyvitamin D is the Probable Cause for Abnormal Calcium Metabolism in Sarcoidosis

Norman H. Bell, Paula H. Stern, Elizabeth Pantzer, Tushar K. Sinha, and Hector F. Deluca

Department of Medicine, Indiana University Medical School, Indianapolis, Indiana 46202

Department of Pharmacology, Indiana University Medical School, Indianapolis, Indiana 46202

Veterans Administration Medical Center, Indianapolis, Indiana 46202

Department of Pharmacology, Northwestern University Medical School, Chicago, Illinois 60611

Department of Biochemistry, University of Wisconsin, Madison, Wisconsin 53706

Find articles by Bell, N. in: PubMed | Google Scholar

Department of Medicine, Indiana University Medical School, Indianapolis, Indiana 46202

Department of Pharmacology, Indiana University Medical School, Indianapolis, Indiana 46202

Veterans Administration Medical Center, Indianapolis, Indiana 46202

Department of Pharmacology, Northwestern University Medical School, Chicago, Illinois 60611

Department of Biochemistry, University of Wisconsin, Madison, Wisconsin 53706

Find articles by Stern, P. in: PubMed | Google Scholar

Department of Medicine, Indiana University Medical School, Indianapolis, Indiana 46202

Department of Pharmacology, Indiana University Medical School, Indianapolis, Indiana 46202

Veterans Administration Medical Center, Indianapolis, Indiana 46202

Department of Pharmacology, Northwestern University Medical School, Chicago, Illinois 60611

Department of Biochemistry, University of Wisconsin, Madison, Wisconsin 53706

Find articles by Pantzer, E. in: PubMed | Google Scholar

Department of Medicine, Indiana University Medical School, Indianapolis, Indiana 46202

Department of Pharmacology, Indiana University Medical School, Indianapolis, Indiana 46202

Veterans Administration Medical Center, Indianapolis, Indiana 46202

Department of Pharmacology, Northwestern University Medical School, Chicago, Illinois 60611

Department of Biochemistry, University of Wisconsin, Madison, Wisconsin 53706

Find articles by Sinha, T. in: PubMed | Google Scholar

Department of Medicine, Indiana University Medical School, Indianapolis, Indiana 46202

Department of Pharmacology, Indiana University Medical School, Indianapolis, Indiana 46202

Veterans Administration Medical Center, Indianapolis, Indiana 46202

Department of Pharmacology, Northwestern University Medical School, Chicago, Illinois 60611

Department of Biochemistry, University of Wisconsin, Madison, Wisconsin 53706

Find articles by Deluca, H. in: PubMed | Google Scholar

Published July 1, 1979 - More info

Published in Volume 64, Issue 1 on July 1, 1979
J Clin Invest. 1979;64(1):218–225. https://doi.org/10.1172/JCI109442.
© 1979 The American Society for Clinical Investigation
Published July 1, 1979 - Version history
View PDF
Abstract

Mean plasma 1α,25-dihydroxyvitamin D[1α,25(OH)2D] was significantly increased and serum parathyroid hormone was suppressed in three patients with sarcoidosis and hypercalcemia. Prednisone lowered the mean plasma 1α,25(OH)2D to normal range and corrected the hypercalcemia. To elucidate the mechanism for the increased sensitivity to vitamin D in this disorder, the effects of orally-administered vitamin D2 were determined in seven normal subjects, four patients with sarcoidosis and normal calcium metabolism and three patients with sarcoidosis and a history of hypercalcemia who were normocalcemic when studied. Serum and urinary calcium, serum 25-hydroxyvitamin D (25-OHD), plasma 1α,25(OH)2D and, in some studies, calcium balance were measured. Vitamin D2, 250 μg a day for 12 d, produced little, if any, change in mean plasma 1α,25(OH)2D and in urinary calcium in the normals and in the patients with normal calcium metabolism. In contrast, vitamin D2 produced increases in plasma 1α,25(OH)2D from concentrations which were within the normal range (20-55 pg/ml) to abnormal values and increased urinary calcium in two patients with abnormal calcium metabolism. In an abbreviated study in the third patient, vitamin D2, 250 μg a day for 4 d, also increased plasma 1α,25(OH)2D abnormally from a normal value. There was a highly significant correlation between plasma 1α,25(OH)2D and urinary calcium. Serum 25-OHD and serum calcium remained within the normal range in all subjects and patients. These findings provide evidence that the defect in calcium metabolism in sarcoidosis probably results from impaired regulation of the production and(or) degradation of 1α,25(OH)2D. Prednisone may act to correct the abnormal calcium metabolism by reducing circulating 1α,25(OH)2D.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 218
page 218
icon of scanned page 219
page 219
icon of scanned page 220
page 220
icon of scanned page 221
page 221
icon of scanned page 222
page 222
icon of scanned page 223
page 223
icon of scanned page 224
page 224
icon of scanned page 225
page 225
Version history
  • Version 1 (July 1, 1979): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts